ARK Genomic Revolution ETF
ARKG
8 hedge funds and large institutions have $3.91M invested in ARK Genomic Revolution ETF in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.
468% more capital invested
Capital invested by funds: $689K → $3.91M (+$3.22M)
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
100% more funds holding
Funds holding: 4 → 8 (+4)
12.66% more ownership
Funds ownership: 6.55% → 19.21% (+13%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EFS
Edelman Financial Services
Fairfax,
Virginia
|
+$2.42M |
| 2 |
CFA
Carroll Financial Associates
Charlotte,
North Carolina
|
+$403K |
| 3 |
LPL Financial
San Diego,
California
|
+$348K |
| 4 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$43.9K |
| 5 |
HFM
Hartford Financial Management
Hartford,
Connecticut
|
+$22.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$317K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EFS
1
Edelman Financial Services
Fairfax,
Virginia
| $2.59M | +$2.42M | +115,898 | New |
|
|
2
LPL Financial
San Diego,
California
| $637K | +$348K | +16,677 | +142% |
|
|
CFA
3
Carroll Financial Associates
Charlotte,
North Carolina
| $433K | +$403K | +19,350 | New |
|
|
LTFS
4
Ladenburg Thalmann Financial Services
Miami,
Florida
| $112K | +$43.9K | +2,104 | +73% |
|
5
Royal Bank of Canada
Toronto,
Ontario, Canada
| $92K | +$14.6K | +700 | +21% |
|
|
HFM
6
Hartford Financial Management
Hartford,
Connecticut
| $24K | +$22.9K | +1,099 | New |
|
|
IA
7
IFP Advisors
Tampa,
Florida
| $20K | +$18.7K | +897 | New |
|
8
Morgan Stanley
New York
| $1K | +$542 | +26 | New |
|
|
9
Jane Street
New York
| – | -$317K | -15,318 | Closed |
|
ARKG Hedge Fund Activity: Q2 2017 in Review
8 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q2 2017, worth a combined $3.91M — up 468% from $689K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ARKG positions and 1 closed out — a net gain of 4 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Edelman Financial Services, opening a new position worth an estimated $2.42M. The largest seller was Jane Street, exiting entirely with an estimated $317K sold.
- 8 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q2 2017, up from 4 in Q1 2017.
- Funds reported $3.91M of ARK Genomic Revolution ETF stock for Q2 2017, up 468% quarter-over-quarter.
- 5 funds opened new ARK Genomic Revolution ETF positions in Q2 2017 and 1 closed out, a net change of +4 holders.
- The largest ARK Genomic Revolution ETF buyer in Q2 2017 was Edelman Financial Services, an estimated $2.42M added.
- The largest ARK Genomic Revolution ETF seller in Q2 2017 was Jane Street, an estimated $317K sold.
Based on aggregated 13F filings for Q2 2017.